Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray G Brown

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Neurology|May 27, 2015
Cost of disease-modifying therapies for multiple sclerosisMurray G Brown
Neurology|April 26, 2015
Escalating MS drug costs in the US: Puzzling, troubling, and suspiciousT Jock Murray, Murray G Brown
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Change and stability in the Canadian healthcare systemMurray G Brown, Vern Hicks, Susan Tett
Healthcarepapers|April 29, 2004
Policy choices for pharmacare; the need to examine benefit design, medication management strategies and evaluationIngrid S Sketris, Murray G Brown, Andrea L Murphy
Annals of Vascular Surgery|March 5, 2003
Mortality, morbidity, and costs of ruptured and elective abdominal aortic aneurysm repairs in Nova Scotia, CanadaHall F Chew, C K You, Murray G Brown, et al.
Plos One|October 21, 2014
Estimating typical multiple sclerosis disability progression speed from clinical observationsMurray G Brown, Mark Asbridge, Vern Hicks, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Neurology|May 27, 2015
Cost of disease-modifying therapies for multiple sclerosisMurray G Brown
Neurology|April 26, 2015
Escalating MS drug costs in the US: Puzzling, troubling, and suspiciousT Jock Murray, Murray G Brown
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Change and stability in the Canadian healthcare systemMurray G Brown, Vern Hicks, Susan Tett
Healthcarepapers|April 29, 2004
Policy choices for pharmacare; the need to examine benefit design, medication management strategies and evaluationIngrid S Sketris, Murray G Brown, Andrea L Murphy
Annals of Vascular Surgery|March 5, 2003
Mortality, morbidity, and costs of ruptured and elective abdominal aortic aneurysm repairs in Nova Scotia, CanadaHall F Chew, C K You, Murray G Brown, et al.
Plos One|October 21, 2014
Estimating typical multiple sclerosis disability progression speed from clinical observationsMurray G Brown, Mark Asbridge, Vern Hicks, et al.
Pageof 1